Novabridge Biosciences ADR (NBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -88,340 | -49,696 | -82,217 | -363,526 | -365,870 |
| Depreciation Amortization | 856 | 978 | 1,061 | 9,253 | 5,357 |
| Accounts receivable | N/A | N/A | N/A | 4,796 | 15,287 |
| Other Working Capital | 17,074 | -2,811 | -37,122 | 80,040 | 61,908 |
| Other Operating Activity | 49,813 | -1,140 | 45,581 | 109,545 | 130,618 |
| Operating Cash Flow | $-20,597 | $-52,669 | $-72,697 | $-159,892 | $-152,700 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 104,925 | -84,914 | -15,000 | 73,100 | -108,475 |
| PPE Investments | 47 | 62 | N/A | N/A | N/A |
| Purchase Of Investment | N/A | -51,115 | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | N/A | -942 |
| Purchase Sale Intangibles | -7 | -48 | -164 | -6,645 | -4,697 |
| Other Investing Activity | -7 | -48 | -164 | -6,641 | -4,697 |
| Investing Cash Flow | $104,965 | $-136,015 | $-15,164 | $66,459 | $-114,114 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | 2,748 | N/A |
| Common Stock Issued | 61,914 | N/A | 407 | 6,474 | 114,950 |
| Common Stock Repurchased | N/A | -335 | -8,644 | -3,081 | N/A |
| Other Financing Activity | -4,189 | 0 | 0 | 0 | -21,750 |
| Financing Cash Flow | $57,725 | $-335 | $-8,237 | $6,141 | $93,200 |
| Exchange Rate Effect | 276 | 573 | 5,197 | 56,429 | -20,207 |
| Beginning Cash Position | 68,263 | 310,667 | 475,371 | 510,879 | 746,756 |
| End Cash Position | 210,632 | 68,263 | 310,667 | 480,016 | 552,935 |
| Net Cash Flow | $142,369 | $-242,404 | $-164,704 | $-30,863 | $-193,821 |
| Free Cash Flow | |||||
| Operating Cash Flow | -20,597 | -52,669 | -72,697 | -159,892 | -152,700 |
| Free Cash Flow | -20,597 | -52,669 | -72,697 | -159,892 | -152,700 |